Akums Drugs Q1FY27 Profit Soars 57.55% to Rs 100 Crore

Akums Drugs and Pharmaceuticals reported a significant 57.55% jump in its consolidated net profit for the first quarter ended June 30, 2026, reaching Rs 100.01 crore. This marks a substantial increase compared to Rs 63.48 crore recorded in the same quarter of the previous fiscal year.

The company’s total consolidated income also saw an uptick, rising by 13.92% to Rs 1,197.01 crore for Q1FY27. This compares to a consolidated income of Rs 1,050.76 crore during the corresponding quarter last year.

Q1FY27 Performance Snapshot

• Consolidated Net Profit: Jumped by 57.55% to Rs 100.01 crore.
• Previous Year Consolidated Net Profit: Rs 63.48 crore.
• Consolidated Total Income: Increased by 13.92% to Rs 1,197.01 crore.
• Previous Year Consolidated Total Income: Rs 1,050.76 crore.

On a standalone basis, the company experienced a marginal 0.07% decline in net profit, settling at Rs 44.84 crore for the quarter, down from Rs 44.87 crore last year. Despite this, standalone total income demonstrated growth, increasing by 15.90% to Rs 418.38 crore from Rs 361.00 crore in the prior corresponding period.

The Q1FY27 results for Akums Drugs and Pharmaceuticals reveal a dual performance, with significant consolidated profit and income growth offsetting a slight contraction in standalone net profit. The overall financial picture indicates expansion in top-line figures across both consolidated and standalone operations.